Olema Pharmaceuticals Inc.

Olema Pharmaceuticals Inc.

World Rank (Aug-2026)
9573
Market Cap (Aug-2026)
0.930 Billion USD
Market Cap (Mar-08-2026)
1.620 Billion USD
World Rank (Jan-05-2024)
10,291
Market Cap (Jan-05-2024)
0.733 Billion USD
World Rank (Jul-30-2023)
15,099
Market Cap (Jul-30-2023)
0.343 Billion USD
World Rank (Jan-07-2022)
16,820
Market Cap (Jan-07-2022)
0.294 Billion USD
World Rank (Jan-01-2021)
5,585
Market Cap (Jan-01-2021)
1.931 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
OLMA
Employee Count
21
Employee Count as of Date
As on 2020
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Operating Income in USD
-179 Million USD
Annual Net Income in USD
-162 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
533 Million USD
Total Liabilities in USD
55 Million USD
Total Equity in USD
479 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biopharmaceutical
Biotechnology
Company Website
OLEMA PHARMACEUTICALS, INC.
Yahoo
Yahoo @ Nasdaq
Company Profile
Olema Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is committed to the discovery, development and commercialization of a transformational generation of targeted therapies for women’s cancers. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share